虚度
发表于 2025-3-26 21:42:38
Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Diseasertality. Glycemic control that is tailored to hemodialysis patients and glycemic control that differs from that of non-dialysis patients are needed to avoid hemodialysis-induced hypoglycemia and other glycemic disarrays.
GENUS
发表于 2025-3-27 02:03:52
Glycemic Metrics and Targets in Kidney Diseasehip between A1C and mortality, with current epidemiological data suggesting that relatively conservative A1C targets may be desirable. Patients with DKD are additionally known to be at particular risk for hypoglycemia, and hypoglycemia avoidance is an important priority when establishing glycemic ta
诱导
发表于 2025-3-27 06:49:29
http://reply.papertrans.cn/31/3098/309705/309705_33.png
寒冷
发表于 2025-3-27 13:11:40
http://reply.papertrans.cn/31/3098/309705/309705_34.png
不连贯
发表于 2025-3-27 15:45:35
http://reply.papertrans.cn/31/3098/309705/309705_35.png
就职
发表于 2025-3-27 21:00:47
http://reply.papertrans.cn/31/3098/309705/309705_36.png
peptic-ulcer
发表于 2025-3-28 01:54:33
Pregnancy in Kidney Diseased no significant increases in maternal mortality. Improved management of comorbidities such as hypertension, intensified dialysis in women with ESKD, and close to attention to management of CKD-associated complications such as volume control and nutrition, anemia, and mineral-bone disease factors is
抛媚眼
发表于 2025-3-28 04:25:31
Lipid Disorders Associated with Chronic Kidney Disease and Nephrotic Syndromen profile. These abnormalities can play a substantial role in pathogenesis and progression of renal and cardiovascular disease in this population. There are many different factors which can impact lipid metabolism and contribute to the nature of lipid abnormalities observed in patients with kidney d
Sputum
发表于 2025-3-28 08:19:26
http://reply.papertrans.cn/31/3098/309705/309705_39.png
乐章
发表于 2025-3-28 12:57:44
Thyroid Status and Outcomes in Kidney Diseasein dialysis patients, possibly due to overlap of its accompanying signs and symptoms with those of uremia (e.g., fatigue, depression, reduced cognition, impaired physical function), as well as attribution of thyroid function test changes to underlying illness rather than primary thyroid disease .